D.B. Cooper is a modern hybrid-indica strain with origins that remain undocumented and thinly sourced. Breeders have not publicly confirmed a definitive lineage, although it is cataloged as a descendant of Mr. Magoo. Due to the lack of transparent breeding records, any assertions regarding the specific circumstances of its development or its precise ancestral history remain speculative. The strain is cultivated in both indoor and outdoor environments, where it demands moderate expertise and rewards the grower with a high yield following a 53-day flowering period.

The chemical composition of D.B. Cooper is complex, defined by a specific confirmed terpene profile that prioritizes caryophyllene, nerolidol, and humulene, followed by myrcene, limonene, linalool, beta-pinene, bisabolol, camphene, isopulegol, pinene, ocimene, terpinolene, gamma-terpinene, and caryophyllene-oxide. Potency figures are an estimated 32% THC with approximately 0% CBD, though these fluctuate depending on the specific harvest and testing environment. Consumers can expect a sensory profile dominated by the spicy, woody notes of caryophyllene and humulene, balanced by the floral and herbaceous nuances of nerolidol and the remaining secondary terpenes within its diverse bouquet.

This strain is primarily chosen for its ability to induce effects of relaxation and focused mental clarity. Given these reported outcomes, it is frequently utilized by individuals seeking relief from physical pain, stress, and sleep disturbances. As a modern hybrid-indica, D.B. Cooper maintains a distinct functional profile, though there are currently no recorded notable offspring established in the wider genetic landscape of the cannabis market.